News and Insights

Pharmaceuticals and Medical Devices

What Population Health Means for Manufacturers

It’s no secret that the healthcare industry is under growing pressure to reduce the cost of care while improving quality. Linkage of payment for healthcare to the cost and quality delivered is the idea behind value-based payment frameworks, and is the driving force behind today’s rapidly changing healthcare landscape. Such…

The Role of Post-Market Studies in Market Access

eyeforpharma

As payers and providers continue to explore ways to reduce healthcare spending and improve patient outcomes, there is a growing trend to require more evidence of product safety and effectiveness across the product lifecycle.  For manufacturers, the failure to develop such data can result in reduced formulary access and lower…

Building Value Considerations into R&D

eyeforpharma

With spiraling cost inflation and lagging quality indicators driving a transition to a value-based system, public and private payers are using sophisticated tools, including health technology assessment (HTA), to evaluate the benefits of medicines. In this environment, companies must demonstrate both clinical efficacy and differentiated economic value to gain optimal…

Transparency Around Value to Support Rational Pricing Discussions

eyeforpharma

The issue of drug pricing has become a staple of the news cycle, with fresh headlines every few weeks spotlighting either the high cost of new breakthrough drugs like Sovaldi, or jaw-dropping price hikes for existing, popular products like the EpiPen. While these examples represent two very different sets of…

The Numerof 2017 Global Medical Device Outlook

Infographic

As our Numerof 2017 Global Medical Device Outlook infographic illustrates, this year’s story for medical device manufacturers will be about dramatically changing roles and relationships.  You’ll continue to engage in new and different ways with regulators, public and private payers, consumers, employers, health care delivery, physicians, retail clinics, and even…

The Numerof 2017 Global Pharma Outlook

Infographic

As our Numerof 2017 Global Pharma Outlook infographic illustrates, this year’s story for pharmaceutical manufacturers will be about adapting to evolving pressures on price and demands for value.  This will create the need for changes in current roles and external relationships.  You’ll continue to engage in new and different ways…